Wednesday, October 17, 2018

Great Lakes fish found heavily contaminated with antidepressant drug chemicals

0

by Isabelle Z. , Natural News:

A new study has found alarmingly high concentrations of human antidepressants in several species of fish in the Niagara River, an important conduit connecting Lake Erie with Lake Ontario.

The researchers discovered the presence of antidepressants and their metabolites in brain tissue in fish such as smallmouth bass, largemouth bass, rock bass, white bass, white perch, yellow perch, steelhead, rudd, bowfin, and walleye.

In the most egregious example, a rock bass had 400 nanograms of a metabolite of the active ingredient in Zoloft, norsertraline, per gram of brain tissue, as well as a cocktail of other drug compounds like the metabolites of Prozac, Celexa and Sarafem. More than half of the fish studied had levels of norsertraline in their brains of 100 nanograms per gram or more.

Lab studies have shown that exposure to these drugs can change fish behavior. While these studies generally expose fish to higher concentrations of the drugs than the levels found in the river, it’s important to keep in mind that the antidepressants in the fish’s brains had accumulated over time, greatly exceeding the levels found in the water of the river itself. For example, the levels of norsertraline found in the brains of three species of bass and the walleye were hundreds of times higher than those of the river water.

Read More @ Naturalnews.com

Swedish Police “Cannot Cope” With Huge Numbers of Rapes Since Migrants Arrived

0

Known rapist who brutally attacked 12-year-old girl still not apprehended 2 months later

by Paul Joseph Watson, Infowars:

A journalist investigating the rape of a 12-year-old girl in Sweden was told that police have not even interviewed the prime suspect two months later because authorities “cannot cope” with the sheer volume of cases since Sweden opened its borders to mass immigration two years ago.

Back in July, the 12-year-old girl was dragged into a restroom by an older man in the center of Stenungsund before being beaten, raped and threatened with death.

Knowing the identity of the culprit, the girl’s mother immediately reported him to police, but authorities have yet to even interrogate the suspect two months later despite knowing his name and address.

According to journalist Joakim Lamotte, the girl is still being confronted and taunted by the rapist on the streets of Stenungsund.

When Lamotte contacted authorities, he was told that the case hasn’t been acted on because police “cannot cope with the workload” of having so many rape cases to investigate.

“Do you know how many rapes we have?” Lamotte was told by the police officer in a conversation he recorded and uploaded to YouTube.

“No, I don’t. But I’ve talked to the mother and her daughter feels very bad because of this, and I know who this man is, I have his name, address, social security number and everything, and, I mean, you haven’t even interrogated him yet, isn’t that remarkable?” asked Lamotte.

Read More @ Infowars.com

Is Metformin a Viable Anti-Aging Solution?

0

by Alexandra Preston, Natural Society:

If you’re a longevity enthusiast, I’ve got some news for you. After all of these years, aging itself is on its way to be officially classified as a disease. Of course, it’s taken decades of improving life expectancy and survival rates due to better living standards and lifestyles, but it is most likely worth the wait.

Why?

This could mean that antiaging will be taken more seriously by the health industry and society as a whole, including insurance companies. It may also raise the value of prevention, instead of just waiting for health problems to appear or reach a certain level of severity before treatment.

So, What Happened Exactly?

Two years ago, researchers managed to convince the United States Food and Drug Administration (FDA) to approve a human lifespan study of metformin, which is currently used for blood sugar control. But it may end up being the first drug approved specifically to ‘treat’ aging.

The study, known as the TAME Study (Targeting Aging With Metformin) started up in 2016, aiming to enroll 3,000 people aged 70-80 and study the effects of metformin over 5-7 years. Everyone must be at risk of or have one or more of the following: cancer, heart disease, or dementia. If metformin can delay or prevent these and delay death, the next step is to test it in younger people.

But why Metformin?

High blood sugar and insulin resistance are key factors in aging and other complex, chronic illnesses, such as cardiovascular disease and cancer. But this is not the only way that metformin could fight aging. Metformin works by acting on an enzyme called AMPK (adenosine monophosphate-activated protein kinase), which regulates how cells process energy.

AMPK boosts metabolism, which may aid weight loss by burning more sugar and fat; it improves blood flow and body composition; it aids cell detoxification and renewal; and it has antioxidant, anti-inflammatory effects.

Read More @ NaturalSociety.com

 

Antifa Goons Almost Get Run Over at Patriot Prayer Rally in Vancouver WA

0

from End Times News Report:

Buy Gold for Long Term as “Fiat Money Is Doomed”

0

by Mark O’Byrne, GoldCore:

– Buy gold for long term as fiat money is doomed warns Frisby
– Gold’s “winning streak” will continue in long term
– September is traditionally a good month for gold, as we head into the Indian wedding season
– “It’s just a matter of time before gold comes good again…”

by Dominic Frisby, Money Week

Today folks, by popular demand, we’re talking gold.
It’s had a nice summer run.
What now?

 

Gold has been buoyed by the North Korea scare

Let’s start with an update. Back in July I suggested a flip trade: buy then in anticipation of a rally, sell in the autumn. But I also ventured that a proper, multi-year bull market in gold, such as the one we saw in the 2000s, was a way off.

The price then was $1,230 an ounce. As I write, we’re a couple of dollars shy of $1,340. We’ve had a $110 rally. Aren’t I a genius?

So what do we do now? Buy more? Sell? Hold?

Let’s have a lively debate.

The first observation I’d make is that a good $30 to $40 of today’s price is war premium. A certain North Korean has been firing missiles and exploding bombs. The world has, quite understandably, got nervous. And a certain American has been positing (with some justification) various potential responses on Twitter.

Is this North Korean affair going to die down and fade away, or is it going to escalate?

Regular readers of this column will be aware that I know the answer to most things, but I confess that here I fall short. This is something of which only a select group of informed North Korean insiders will have concrete knowledge.

But how this affair pans out will determine gold’s direction in the short term. If it escalates, gold goes up. If it doesn’t, then that $30 or $40 of war premium will be given back.

I’d wager that this is just noise, albeit rather scary noise, and that it will pass. But this is no more than a guess, and not even an informed one.

Aside from North Korea, over the last 45 years, September has proved a good month for gold, rising by an average of about 2.5{5f621241b214ad2ec6cd4f506191303eb2f57539ef282de243c880c2b328a528}. The given reason for this is that gold buying increases as we head into the Indian wedding season, which runs from October to December. Indians are the biggest buyers of physical metals. About a third of global physical gold demand comes from India, half of which is spent on jewellery for their ten million weddings each year.

Read More @ GoldCore.com

BBC dog whistle politics over pewdiepie

0

from RobinHoodUKIP:

Idaho earthquake swarm: Over 200 quakes in past 9 days

0

from Intellihub:

Scientists fear that the big one could be on the way as a recent earthquake swarm intensifies east of Soda Springs

(INTELLIHUB) — More than 204 earthquakes have struck west of Soda Springs, Idaho since Sept. 2 in a swarm that scientists fear could end with a big one.

34 of the earthquakes were felt on Sunday alone, according to a report by the Idaho State Journal, showing that the swarm may be intensifying.

“Dr. David Pearson, an Idaho State University geologist who studies earthquakes, said scientists who have researched some of the faults in Southeast Idaho have concluded that the 7.0 quake is possible at some point in the region’s future, but the current earthquake swarm is not necessarily an indication that it will occur anytime soon.”

Read More @ intellihub.com

Hurricane Harvey and the economy

0

from Boom Bust:

Bitter Hillary: Trump Won Because He Comforted ‘Millions of White People’

0

by Steve Watson, Infowars.com :

In an interview to promoter her book about losing the election to Donald Trump, Hillary Clinton claimed that she lost because Trump ran a campaign of nostalgia and it was a ‘comfort’ to ‘millions of white people’.

“He was quite successful in referencing the nostalgia that would give hope, comfort, settle grievances, for millions of people who were upset about gains that were made by others,” Clinton stated during the CBS interview, aired Sunday.

“What you’re saying is millions of white people,” interviewer Jane Pauley stated.

“Millions of white people,” Clinton confirmed. “Yeah, millions of white people.”

Clinton also blamed ‘sexism and misogyny’ for her loss, and claimed that a majority of Americans felt ‘we really don’t want a woman commander in chief’.

At no point did Clinton admit that it was her own scandal ridden history that could have contributed to her loss.

Hillary was also asked about her infamous ‘deplorables’ comment, to which she revealed she actually still stands by:

Read More @ Infowars.com

NASA Model Flawed for Huge Solar Blast | S0 News Sept.11.2017

0

from Suspicious Observers:

Elon Musk Magically Extends Battery Life Of Teslas Fleeing Irma

0

from ZeroHedge:

In what is either a generous act of charity or an unnerving example of the control Tesla exercises over the vehicles it producers, or perhaps both, Tesla CEO Elon Musk has magically unlocked the batteries of every Tesla in Florida to maximize the distance that people fleeing from Hurricane Irma can travel before stopping to refuel at one of the company’s “superstation” charging centers.

Typically, these types of over-the-air upgrades can cost thousands – if not tens of thousands – of dollars.

But Musk is temporarily offering full battery capacity to all owners of Model S/X 60/60D vehicles with 75 kilo watt battery packs, according to Electrek, a blog that covers electric vehicles.

The upgrade will surely help Floridians who are still rushing to escape as the now category 3 storm makes its second landfall near Naples. The upgrade will last through Saturday.

As a Tesla spokesperson explained to Electrek, the company decided on the mass-unlocking strategy after a customer called and asked if the company could upgrade his battery because he was trying to flee the storm. Tesla’s Supercharger network is fairly extensive in Florida and most owners should be able to get by even with a Model S 60 (the shortest range option).

A Tesla Model S 60 owner in Florida told Electrek that his Tesla was getting 40 more miles without a charge after Tesla had temporarily unlocked the remaining 15 kilo watts of the car’s software-limited battery pack.

“The company says that a Tesla owner in a mandatory evacuation zone required another ~30 more miles of range to optimize his evacuation route in the traffic and they reached out to Tesla who agreed to a temporary access to the full 75 kWh of energy in the battery pack, an upgrade that has cost between $4,500 and $9,000 depending on the model and time of upgrade.”

The company also decided to temporarily unlock other vehicles with the same software-lock battery packs in the region.

Tesla’s supercharger network is fairly extensive in Florida and most owners should be able to get by even with a Model S 60 (the shortest range option), but sometimes that 30 more miles of range can make a big difference.

Most of the supercharger stations in the state are still open:

Read More @ ZeroHedge.com

Could This Be The Biggest Biotech Breakthrough Of The Year?

0

from OilPrice, Market Oracle:

Someone dies of a stroke every 4 minutes in the United States. Globally, 15 million people suffer a stroke every year. It’s debilitating physically and financially—but one little-known company has developed a medical device that hopes to challenge that deadly statistic.

It’s been quietly developing this new technology for 10 years. Now it’s released updated preliminary clinical trial results, and signed a manufacturing deal which could make a significant impact in the medical device industry.

After a decade of painstaking development, we’re now nearing the end of the long road to validation, and for investors who understand this industry, this could be the critical juncture.

The little-known company is CVR Medical (TSX:CVM.VOTC:CRRVF), and its potentially life-saving device is the Carotid Stenotic Scan (CSS)–a technology designed to detect stenosis within arteries, or Ischemia, which is the leading indicator of strokes.

Of the 15 million people who suffer stroke every year, some 6 million are killed, while 5 million are rendered permanently disabled, according to the World Heart Foundation.

But there has been no cost-effective way to screen for Ischemia.

So, when a biotech company offers a potential solution to help prevent the second-leading cause of death in the world–and then releases positive preliminary clinical trial results, investors listen.

Now it’s hoping to charge out of the gate and take the market by storm once it manages to gain FDA market clearance.

In the meantime, the catalysts are really lining up:

On 7 September, CVR released updated results from its preliminary clinical trial that showed forward progress for the medical device, which we’ve been watching closely for some time. You can view the results from Thomas Jefferson University HERE.

And a few weeks prior, they announced another landmark achievement when they signed a letter of intent to manufacture the CSS. The deal gives CVR state-of-the-art manufacturing capabilities with Canon Virginia, Inc (CVI). This would give CVR immediate scalability, and also adds to its credibility: It’s not the first manufacturing deal the company has sealed.

Our researchers are keeping a close eye on CVR Medical Corp. because we think this is the turning point. Here’s why:

  • It’s had two fresh catalysts in three weeks in an industry that is all about validation
  • It’s developing a device that meets critical demand in terms of helping to prevent one of the most debilitating and deadly diseases of our time
  • It’s developing a medical device that actually makes sense to the market
  • It’s been doing it quietly, without blockbuster hype, and instead painstakingly going for real validation, making it the real deal.

Here are 5 reasons to keep a close eye on CVR Medical (TSX:CVM.VOTC:CRRVF) in the coming weeks and months:

#1 Catalysts are Lining Up, and News Flow is Gaining Momentum

First, one way to look at the CSS is to think about what 3D seismic imagery did for super quick discoveries in the oil and gas industry. This is exactly what CVR’s sensory system could do for the medical industry in terms of detecting critical stroke symptoms.

This is how it works:

CVR’s Carotid Stenotic Scan (CSS) is a tool to detect blockage within the Carotid Arteries, potentially offering patients and caregivers a device for early detection in a quick and repeatable manner.

The CSS makes a connection between fluid flow and low frequency soundwaves to detect arterial disease or blockage. Blood flowing through the carotid arteries produces wave patterns which are shaped and altered by the presence of irregularities on the inner artery walls.

CVR’s advanced technology captures these wave patterns and analyzes them mathematically with patented algorithms. After a brief test, the analysis is complete, offering a way to potentially identify those at risk of a stroke and arming the healthcare provider with the information necessary to prevent the deadly event.

Unlike other comparative modalities, the CSS was designed to function without the assistance of a certified technician. These three facts combine to create one of the potentially biggest—and most lucrative–phenomena in recent medical equipment market history.

The updated results of the preliminary clinical trials released just now bring the benefits of this device that much closer. Not only could it potentially help prevent strokes through early detection of arterial disease, but there is a secondary benefit: if all goes according to plan, it makes testing cheap, affordable and accessible to all.

Read More @ MarketOracle.co.uk